Pfizer Inc (NYSE:PFE)
| 41.49 BATS BZX Real-Time Price As of Oct 15 |  0.00 / 0.00%Today’s Change | 32.80 Today|||52-Week Range 51.86 | +12.71% Year-to-Date |
Latest PFE News | Press Releases
| Is Moderna a Good Healthcare Stock to Buy Now? 8:34am / MotleyFool.com - Paid Partner Content | Can This COVID Vaccine Stock Help Make You Rich? Oct 16 / MotleyFool.com - Paid Partner Content |
| 2 Top Biotech Stocks to Buy in October 6:05am / MotleyFool.com - Paid Partner Content | Europe Recommends Pfizer Boosters for Ages 18 and Up: Could the U.S. Soon Follow? Oct 16 / MotleyFool.com - Paid Partner Content |
| 2 Bargain Stocks You Can Buy Today and Hold Forever 6:00am / MotleyFool.com - Paid Partner Content | 2 Top Healthcare Stocks That Could Be Bought Out in 2022 Oct 16 / MotleyFool.com - Paid Partner Content |
| Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine? Oct 17 / MotleyFool.com - Paid Partner Content | 3 COVID-19 Pill Stocks to Watch Oct 16 / MotleyFool.com - Paid Partner Content |
| Is Ocugen Stock Heading for a Crash? Oct 17 / MotleyFool.com - Paid Partner Content | Better COVID-19 Stock: Merck or Pfizer? Oct 16 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 41.49 |
| Today’s open | 41.90 |
| Day’s range | 41.39 - 42.02 |
| Volume | 23,550,344 |
| Average volume (3 months) | 29,544,651 |
| Market cap | $232.6B |
Data as of 5:43pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -40.76% |
| Earnings growth (this year) | +82.07% |
| Earnings growth (next 5 years) | +3.23% |
| Revenue growth (last year) | -19.02% |
| P/E ratio | 19.0 |
| Price/Sales | 4.95 |
| Price/Book | 3.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | +0.09 | +0.04% |
| MRKMerck | 0.00 | 0.00% |
| ABBVAbbVie | +0.03 | +0.03% |
| AZNAstraZeneca | 0.00 | 0.00% |
Data as of 5:57pm ET, 10/15/2021
Financials
| Next reporting date | November 2, 2021 |
| EPS forecast (this quarter) | $1.08 |
| Annual revenue (last year) | $41.9B |
| Annual profit (last year) | $9.6B |
| Net profit margin | 16.67% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
